Forbes lists personalized healthcare as one of the primary healthcare trends that will drive advancements in healthcare next year. With new, AI-driven tools, healthcare providers can unlock powerful insights and tailor care to each patient. Our FDA-cleared technology platform, BNA™, harnesses the power of AI to provide healthcare professionals an unparalleled understanding of brain activity, allowing them to customize treatment plans and promote better patient outcomes. https://lnkd.in/ehKA4QSY #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare
Firefly Neuroscience
Medical Equipment Manufacturing
Buffalo עוקבים, New York 5,968
Revolutionalizing Brain Health with the power of objective, AI-driven assessments.
עלינו
Welcome to the future of neurological assessments with Firefly Neuroscience’s FDA-cleared Brain Network Analytics (BNA™). Utilizing ADVANCED AI and an extensive proprietary EEG database, BNA™ combines the automatic analysis of Event-Related Potentials (ERPs), spectral EEG, and behavioral performance data for a comprehensive and objective data-driven brain health evaluation.
- אתר אינטרנט
-
http://www.fireflyneuro.com
קישור חיצוני עבור Firefly Neuroscience
- תעשייה
- Medical Equipment Manufacturing
- גודל החברה
- 11-50 עובדים
- משרדים ראשיים
- Buffalo, New York
- סוג
- בבעלות פרטית
- הקמה
- 2006
מיקומים
-
הראשי
1100 Military Rd
Buffalo, New York 14217, US
-
407 Iroquois Shore Rd
Oakville, Ontario L6H 1M3, CA
-
1 Shenkar Street
Herzliya, Israel 4672501, IL
עובדים ב- Firefly Neuroscience
-
Stella K. Vnook
Chief Executive Officer | Founder & President Biopharma Companies | Board Chair | Advisor | Mentor | Investor | Licensing | M&A | Strategy |…
-
Motti Kleinmann
Director, China Program at ElMindA
-
Jason DuBraski
VP of Sales
-
Samer Kaba, M.D.
Pharmaceutical Development Consultant, Chief Medical Officer, Advisory Board Member, and VC Advisor.
עדכונים
-
Firefly’s FDA-cleared BNA™ platform is powered by advanced AI technology that transforms vast EEG data into critical insights to continuously refine clinicians’ understanding and treatment of neurological conditions. Developed using a proprietary, standardized database encompassing scans from over 17,000 individuals, Firefly’s technology provides extensive data-driven assessments of brain activity to help drive neurological research and personalized care. Learn more: https://fireflyneuro.com/ #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare
-
Our Director of National Accounts, Laura S., is joining Zeto / Rapid Full-Montage EEG this weekend at the American Epilepsy Society’s Annual Meeting at the Los Angeles Convention Center. Stop by Zeto Booth #1219 on December 7 and 8 from 1 – 2 pm to hear about our AI-driven BNA™ technology and discover how our partnership with Zeto can advance care for epilepsy and other neurological conditions. #AES2024 #Neurology #EEG #Healthcare #ArtificialIntelligence
-
With Firefly’s AI-powered BNA™ platform, healthcare providers can extract next-generation brain health insights from a simple recording session. After measuring brain activity at rest and during a series of cognitive tasks, the platform uploads information to the cloud, where our patented AI algorithms perform advanced analysis to establish personalized cognitive measures. These measures are then compared to our extensive age-matched normative database to equip healthcare professionals with an objective assessment of each patients’ brain activity. Get started today: https://lnkd.in/dFfvAem4 #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare
-
How does Firefly’s BNA™ technology unlock a deeper understanding of brain activity? Every psychiatric and neurological condition is unique, and some conditions only affect task performance at more progressed stages or during complex tasks. Our BNA™ platform Behavioral Report helps clinicians and neurologists better understand the severity and progression of each patient’s condition, unlocking a deeper understanding of brain activity. Learn more about how BNA™can transform your practice: https://lnkd.in/emHuWVVU #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare
-
Our CEO, Jon Olsen, sat down with Authority Magazine to discuss his passion for developing innovative technologies, Firefly’s work to disrupt the standard of neurological care and what’s ahead for the company in 2025. “I believe what we are doing at Firefly will disrupt the standard of care and improve outcomes for patients suffering from brain health illnesses and disorders by providing clinicians with the ability to objectively assess brain health,” he shared. Read more: https://lnkd.in/eNq26FWn #Innovation #HealthcareTechnology #ArtificialIntelligence #Neuroscience #BrainHealth
Meet The Disruptors: Jon Olsen Of Firefly Neuroscience On The Five Things You Need to Shake Up Your…
medium.com
-
Firefly’s BNA™ technology has the potential to revolutionize brain health by allowing healthcare providers to track disease progression over time and evaluate the effectiveness of treatments. With BNA™’s advanced, AI-driven technology, clinicians and neurologists can compare a patient’s current results to baseline measurements in the initial report in order to monitor progress and personalize treatment plans. Ready to harness the power of BNA™? Contact us: https://lnkd.in/gJ_2ngYx #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare
-
Firefly Neuroscience’s BNA™ is poised to revolutionize the brain healthcare industry through our unique AI capabilities and next generation neurological insights. BNA™’s AI-based EEG analysis encompasses ERP, quantitative spectral EEG and behavioral results – all in one FDA-cleared tool. Unlike the current standard of neurological care, which often relies on manual interpretation and a trial and error treatment approach, our advanced technology allows for a deeper understanding of brain activity by providing quantifiable, data-driven insights. Discover how you can integrate BNA™ into your practice to improve patient care and drive better outcomes: https://lnkd.in/dFfvAem4 #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare
-
How is Firefly driving the future of neurological assessments and personalized brain health care? Our FDA-cleared BNA™ platform equips healthcare professionals with comprehensive insights into neural activity by leveraging Event Related Potentials (ERPs), quantitative spectral EEG, behavioral results and advanced AI analysis. This objective assessment provides clinicians and neurologists with a deeper understanding of each patient’s brain function that allows them to tailor treatments according to their unique needs. Learn more about BNA™ and its potential to revolutionize neurological care: https://fireflyneuro.com/ #Healthcare #ArtificialIntelligence #Neuroscience #BrainHealth #AIinHealthcare
-
Memory loss is becoming increasingly prevalent in older generations, but many seniors remain unaware of the extent of their cognitive decline. By equipping healthcare providers with AI-driven BNA™ technology, Firefly Neuroscience aims to fundamentally change the way we identify and treat cognitive decline as patients age. Our advanced, FDA-cleared platform measures cognitive function using EEG with ERPs, comparing the results to an age-matched, normalized data set as well as patients’ past results to provide a comprehensive quantitative analysis of cognitive function. These powerful insights can help healthcare professionals better understand their patients’ cognitive health, personalize treatment and improve patient outcomes. #CognitiveFunction #BrainHealth #Neuroscience #ArtificialIntelligence
How Undiagnosed Cognitive Decline Eats Into Seniors’ Retirement Savings
wsj.com